The trademark FEMAGINAL was filed by Capricorn Life Sciences B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on March 1, 2020, and received one opposition filed on May 19, 2020 by Apogepha Arzneimittel GmbH on Likelihood of confusion. the opponent was represented by KAILUWEIT & UHLEMANN PATENTANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 19, 2020
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on September 24, 2020.